Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 593-603 , July 2010

Validation of two fluoro-analogues of N,N-dimethyl-2-(2′-amino-4′-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET

Received 15 January 2010 ,Revised 25 February 2010 ,Accepted 8 March 2010.

References 

  1. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry. 1998;44:151–162
  2. Sen S, Villafuerte S, Nesse R, Stoltenberg SF, Hopcian J, Gleiberman L, et al. Serotonin transporter and GABA(A) alpha 6 receptor variants are associated with neuroticism. Biol Psychiatry. 2004;55:244–249
  3. Iversen L. Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry. 2000;5:357–362
  4. Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatry Res. 2007;41:189–206
  5. Chen CP, Alder JT, Bowen DM, Esiri MM, McDonald B, Hope T, et al. Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlation with depression and neuroleptic medication. J Neurochem. 1996;66:1592–1598
  6. Blier P, de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology. 1999;21:91S–98S
  7. Wang JL, Parhi AK, Oya S, Lieberman B, Kung HF. In vivo characterization of a series of 18F-diaryl sulfides (18F-2-(2′-((dimethylamino)methyl)-4′-(fluoroalkoxy)phenylthio)benzenamine) for PET imaging of the serotonin transporter. J Nucl Med. 2009;50:1509–1517
  8. Sorgi KL, Maryanoff CA, McComsey DF, Graden DW, Maryanoff BE. Asymmetric induction in an enammonium-iminium rearrangement. Mechanistic insight via NMR, deuterium labeling, and reaction rate studies. Application to the stereoselective synthesis of the pyrroloisoquinoline antidepressants. J Am Chem Soc. 1990;112:3567–3583
  9. Jagust WJ, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, et al. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med. 1996;37:1207–1214
  10. Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, et al. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4′-((Z-2-iodoethenyl)phenyl)-nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission-tomography. J Med Chem. 2003;46:925–935
  11. Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, et al. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4′-((Z)-2-haloethenyl)phenyl)tropanes: candidate radioligands for in vivo imaging of the serotonin transporter. J Med Chem. 2004;47:1122–1135
  12. Stehouwer JS, Jarkas N, Plisson C, Zeng F, Voll RJ, Williams L, et al. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 (N-fluoroalkyl) labeled 2beta-carbomethoxy-3beta-(4′-(3-furyl)phenyl) tropanes and nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. J Med Chem. 2005;48:7080–7083
  13. Plisson C, Jarkas N, McConathy J, Voll RJ, Williams L, Howell L, et al. Evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-[4′-((Z)-2-iodoethenylfuryl)phenyl] nortropane as a potential radioligand for imaging the serotonin transporter by PET. J Med Chem. 2006;49:942–946
  14. Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Owens MJ, et al. Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3′-((Z)-2-haloethenyl)phenyl) nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. J Med Chem. 2006;49:6760–6767
  15. Plisson C, Stehouwer JS, Voll RJ, Howell LL, Votaw JR, Goodman MM. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4′-((Z)-2-iodoethenyl)phenyl nortropane as a candidate serotonin transporter imaging agent. J Med Chem. 2007;50:4553–4560
  16. Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Camp VM, et al. Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3′-((Z)-2-haloethenyl)phenyl nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. J Med Chem. 2008;51:7788–7799
  17. Ferris RM, Brieaddy L, Mehta N, Hollingsworth E, Rigdon G, Wang C, et al. Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine and noradrenaline-reuptake inhibitor. J Pharm Pharmacol. 1995;47:775–781
  18. Oya S, Kung MP, Acton PD, Mu M, Hou C, Kung HF. A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol. J Med Chem. 1999;42:333–335
  19. Zhuang ZP, Choi SR, Hou C, Mu M, Kung MP, Acton PD, et al. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol. Nucl Med Biol. 2000;27:169–175
  20. Lin KJ, Liu CY, Wey SP, Hsiao IT, Wu J, Fu YK, et al. Brain SPECT imaging and whole-body biodistribution with [123I]ADAM-a serotonin transporter radiotracer in healthy human subjects. Nucl Med Biol. 2006;33:193–202
  21. Frokjaer VG, Pinborg LH, Madsen J, de Nijs R, Svarer C, Wagner A, et al. Evaluation of the serotonin transporter ligand 123I-ADAM for SPECT studies on humans. J Nucl Med. 2008;49:247–254
  22. Wilson AA, Houle S. Radiosynthesis of carbon-11 labelled N-methyl-2-(arylthio)benzylamines: potential radiotracers for the serotonin reuptake receptor. J Labelled Compd Radiopharm. 1999;42:1277–1288
  23. Houle S, Ginovart N, Hussey D, Meyer JH, Wilson AA. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB. Eur J Nucl Med. 2000;27:1719–1722
  24. Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlked PG, Houle S. Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of C-labeled 2-(phenylthio)araalkylamines. J Med Chem. 2000;43:3103–3110
  25. Oya S, Choi SR, Coenen H, Kung HF. New PET imaging agent for the serotonin transporter: [18F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio-N,N-dimethyl-benzenmethanamine. J Med Chem. 2002;45:4716–4723
  26. Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vitro evaluation of fluorine-18 compounds as PET imaging agents. J Med Chem. 2005;48:2559–2570
  27. Parhi AK, Wang JL, Oya S, Choi SR, Kung MP, Kung HF. 2-(2′-((Dimethylamino)methyl)-4′-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents. J Med Chem. 2007;50:6673–6684
  28. Frankle WG, Slifstein M, Gunn RN, Huang Y, Hwang DR, Darr EA, et al. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans. J Nucl Med. 2006;47:815–826
  29. Jarkas N, McConathy J, Voll RJ, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2′-amino-4′-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands. J Med Chem. 2005;48:4254–4265
  30. Jarkas N, Voll RJ, Williams L, Votaw JR, Owens M, Goodman MM. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2′-amino-4′-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands. J Med Chem. 2008;51:271–281
  31. Jarkas N, Votaw JR, Voll RJ, Williams L, Camp VM, Owens MJ, et al. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters. Nucl Med Biol. 2005;32:211–224
  32. Nye JA, Votaw JR, Jarkas N, Purselle D, Camp V, Bremner JD, et al. Compartmental modeling of 11C-HOMADAM binding to the serotonin transporter in the healthy human brain. J Nucl Med. 2008;49:2018–2025
  33. Van Der Stelt C, Van Der Lugt W, Nauta WT. The synthesis of 2-mercapto-4-aminobenzoic acid. Recueil Trav Chim. 1951;70:285–288
  34. Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux EJ, Camp VM, et al. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Nucl Med Biol. 2005;32:75–86
  35. Lemaire C, Plenevaux A, Aerts J, Del Fiore G, Brihaye C, Le Bars D, et al. Solid phase extraction-an alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals. J Labelled Compd Radiopharm. 1999;42:63–75
  36. Jung ME, Dansereau MK. Benzo[H]-1,6-naphthyridine synthesis via intramolecular Diels-Alder reactions of aryl oxazoles: synthetic approach to 2-bromoleptoclinidinone. Heterocycles. 1994;39:767–778
  37. Kalinin AV, Bower JF, Riebel P, Snieckus V. The direct orthometallation-Ullmann connection. A new Cu(I)-catalysed variant for the synthesis of substituted diaryl ethers. J Org Chem. 1999;64:2986–2987

PII: S0969-8051(10)00061-2

doi: 10.1016/j.nucmedbio.2010.03.004

Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 593-603 , July 2010

Article Tools

* Image Usage & Resolution